Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Sysmex corporation japan (scj) determined that in rare cases intermittent elevated hemoglobin (hgb) and/or impedance platelet counts (pl t-1) occur due to residual dried blood present on sample tube cap falling into the red blood cell (rbc)/pl t-1/hgb chamber used for the dilution and counting or rbc/pl t-1 and measurement of hemoglobin concentration.